CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2020. The put-call ratio across all filers is 0.11 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $34,000 | 0.0% | 285 | 0.0% | 0.00% | – |
| Q4 2020 | $34,000 | +78.9% | 285 | +70.7% | 0.00% | – |
| Q3 2020 | $19,000 | +850.0% | 167 | +659.1% | 0.00% | – |
| Q1 2020 | $2,000 | -100.0% | 22 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $8,011,000 | +496.9% | 69,986 | +397.1% | 0.06% | +441.7% |
| Q2 2019 | $1,342,000 | +886.8% | 14,078 | +842.9% | 0.01% | +500.0% |
| Q1 2019 | $136,000 | -83.4% | 1,493 | -86.2% | 0.00% | -71.4% |
| Q4 2018 | $820,000 | – | 10,808 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |